Please ensure Javascript is enabled for purposes of website accessibility

Lilly’s Weight-Loss Pill Wins US Approval

The U.S. Food and Drug Administration on Wednesday approved Eli Lilly's weight-loss pill, making it the second to market after Novo Nordisk's oral Wegovy, as the companies fight to capture more customers with the convenience of pills over injectables. The Lilly drug, orforglipron, which will be sold under the brand...

Oil Slides as Middle East Uncertainty Keeps Markets on Edge

Oil reversed earlier gains on Wednesday as uncertainty over the situation in the Middle East unnerved markets and U.S. President Donald Trump again suggested the U.S.-Israeli war with Iran could be nearing an end. The front-month Brent contract for June fell $1.85, or 1.8%, to $102.12 per barrel at 1414...

Search

Keep the news you rely on coming. Support our work today.